Vimarsana
Biggest News Aggregation in the World

Page 11 - Daniel Grosslight News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel Grosslight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Grosslight Today - Breaking & Trending Today

23andMe Holding Co. (NASDAQ:ME) Q3 2023 Earnings Call Transcript - Vimarsana News

23andMe Holding Co. (NASDAQ:ME) Q3 2023 Earnings Call Transcript

Operator: Good day, and welcome to 23andMe's Fiscal Year 2023 Third Quarter Financial Results Conference Call. At a reminder, this call is being recorded.

SelectQuote, Inc. (NYSE:SLQT) Q2 2023 Earnings Call Transcript - Vimarsana News

SelectQuote, Inc. (NYSE:SLQT) Q2 2023 Earnings Call Transcript

Operator: Hello and welcome to SelectQuote's second quarter fiscal year 2023 earnings conference call. My name is Dru and I'll be your operator today.

SelectQuote (SLQT) Q2 2023 Earnings Call Transcript - Vimarsana News

SelectQuote (SLQT) Q2 2023 Earnings Call Transcript

SLQT earnings call for the period ending December 31, 2022.

Source: fool.com
Digital Health Funding Will Be Brutal in 2023 - Vimarsana News

Digital Health Funding Will Be Brutal in 2023

Investors were racing each other to back digital health startups. Overnight, they've raised the bar for who gets funded. Many startups won't meet it.

Is Amazon's RxPass Breaking New Ground in Creating Access to Affordable Drugs? - Vimarsana News

Is Amazon's RxPass Breaking New Ground in Creating Access to Affordable Drugs?

Amazon's RxPass offers more than 50 generic drugs for more than 80 common conditions at the flat fee of $5 a month for Prime members. While one expert says its a significant move by Amazon, another said more needs to be done.